Literature DB >> 8018583

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.

H Katila1, B Appelberg, M Hurme, R Rimón.   

Abstract

Plasma levels of interleukin (IL)-1 beta and IL-6 were measured in 60 acutely hospitalized psychiatric patients and in 60 healthy controls by enzyme-linked immunosorbent assay (ELISA). Almost no IL-6 was detected in the plasma of the patients or controls. The mean level of IL-1 beta was found to be significantly higher in schizophrenic patients than in their corresponding controls (P = 0.03). The acute schizophrenics, but not the group of chronic schizophrenics, contributed to this increase. No correlation with age, duration of illness or overt psychopathology was found. The neuroleptic medication did not prove to have a significant effect on the plasma IL-1 beta levels. There was no difference between non-psychotic affective disorder patients (N = 17) and the controls.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018583     DOI: 10.1016/0920-9964(94)90081-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

Review 1.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

Review 2.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

3.  A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.

Authors:  Edwin J C G van den Oord; Shaunna L Clark; Lin Ying Xie; Andrey A Shabalin; Mikhail G Dozmorov; Gaurav Kumar; Vladimir I Vladimirov; Patrik K E Magnusson; Karolina A Aberg
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

Review 4.  Inflammatory biomarkers and depression.

Authors:  Norbert Müller; Aye-Mu Myint; Markus J Schwarz
Journal:  Neurotox Res       Date:  2010-07-24       Impact factor: 3.911

5.  Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.

Authors:  U H Frommberger; J Bauer; P Haselbauer; A Fräulin; D Riemann; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 6.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

7.  Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.

Authors:  Kari Hänninen; Heikki Katila; Marika Saarela; Riikka Rontu; Kari M Mattila; Meng Fan; Mikko Hurme; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

Review 8.  [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

Authors:  A Schuld; D Hinze-Selch; Th Pollmächer
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 9.  The impact of inflammation on neurocognition and risk for psychosis: a critical review.

Authors:  Sophia Kogan; Luz H Ospina; Vijay A Mittal; David Kimhy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-10-16       Impact factor: 5.270

10.  Genome-wide association study of treatment refractory schizophrenia in Han Chinese.

Authors:  Ying-Jay Liou; Hui-Hung Wang; Ming-Ta Michael Lee; Sheng-Chang Wang; Hung-Lun Chiang; Cheng-Chung Chen; Ching-Hua Lin; Ming-Shun Chung; Chien-Cheng Kuo; Ding-Lieh Liao; Ching-Kuan Wu; Chih-Min Liu; Yu-Li Liu; Hai-Gwo Hwu; I-Ching Lai; Shih-Jen Tsai; Chia-Hsiang Chen; Hui-Fen Liu; Yi-Chun Chou; Chien-Hsiun Chen; Yuan-Tsong Chen; Chen-Jee Hong; Jer-Yuarn Wu
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.